Experimental pill added to chemo for tough pancreatic cancer
NCT ID NCT05497778
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial is testing whether adding an experimental drug called IM156 to standard chemotherapy (gemcitabine and nab-paclitaxel) is safe and tolerable for people with advanced pancreatic cancer. The study involves 19 participants and is being run by M.D. Anderson Cancer Center. The main goal is to check for side effects, but researchers will also look at whether the combination might help control the cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- IM156 (an experimental drug taken by mouth) plus gemcitabine and nab-paclitaxel (standard chemotherapy drugs given by IV)
- What this could lead to
- If it works, this could point toward a new combination treatment for advanced pancreatic cancer that is safe and may help control the disease.
- What could go wrong
- This is a very early Phase 1 trial with only 19 people, focused on safety. It is too small and early to know if the combination actually helps patients live longer or better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug immune attack shrink Hard-to-Treat pancreatic tumors?
- Can a pill rouse the immune system against pancreatic cancer?
- Can a new ultrasound technique spot hidden pancreatic cancers earlier?
- Can a targeted antibody give pancreatic cancer chemo a boost?
- A simple breath test might spot multiple cancers before symptoms appear
- Can High-Dose vitamin c boost Chemo's punch against pancreatic cancer?